Clinical Trial Update: Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period

View source ↗

Summary

A prospective, multicenter non-interventional study evaluated adherence to Betaferon (interferon beta-1b) over two years in people with Multiple Sclerosis; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED